Zhang Yanghui, Gaekwad Jidnyasa, Wolfert Margreet A, Boons Geert-Jan
Complex Carbohydrate Research Center, The University of Georgia, 315 Riverbend Road, Athens, GA 30602, USA.
Chemistry. 2008;14(2):558-69. doi: 10.1002/chem.200701165.
Differences in the pattern and chemical nature of fatty acids of lipid A of Neisseria meningitides lipooligosaccharides (LOS) and Escherichia coli lipopolysaccharides (LPS) may account for differences in inflammatory properties. Furthermore, there are indications that dimeric 3-deoxy-D-manno-oct-2-ulosonic acid (KDO) moieties of LOS and LPS enhance biological activities. Heterogeneity in the structure of lipid A and possible contaminations with other inflammatory components have made it difficult to confirm these observations. To address these problems, a highly convergent approach for the synthesis of a lipid A derivative containing KDO has been developed, which relies on the ability to selectively remove or unmask in a sequential manner an isopropylidene acetal, 9-fluorenylmethoxycarbonyl (Fmoc), allyloxycarbonate (Alloc), azide, and thexyldimethylsilyl (TDS) ether. The strategy was employed for the synthesis of N. meningitidis lipid A containing KDO (3). Mouse macrophages were exposed to the synthetic compound and its parent LOS, E. coli lipid A (2), and a hybrid derivative (4) that has the asymmetrical acylation pattern of E. coli lipid A, but the shorter lipids of meningococcal lipid A. The resulting supernatants were examined for tumor necrosis factor alpha (TNF-alpha) and interferon beta (IFN-beta) production. The lipid A derivative containing KDO was much more active than lipid A alone and just slightly less active than its parent LOS, indicating that one KDO moiety is sufficient for full activity of TNF-alpha and IFN-beta induction. The lipid A of N. meningitidis was a significantly more potent inducer of TNF-alpha and IFN-beta than E. coli lipid A, which is due to a number of shorter fatty acids. The compounds did not demonstrate a bias towards a MyD88- or TRIF-dependent response.
脑膜炎奈瑟菌脂寡糖(LOS)和大肠杆菌脂多糖(LPS)中脂质A的脂肪酸模式和化学性质差异可能解释其炎症特性的差异。此外,有迹象表明LOS和LPS的二聚3-脱氧-D-甘露糖-2-辛酮酸(KDO)部分可增强生物活性。脂质A结构的异质性以及可能被其他炎症成分污染使得难以证实这些观察结果。为了解决这些问题,已开发出一种高度收敛的方法来合成含KDO的脂质A衍生物,该方法依赖于以顺序方式选择性去除或解开异亚丙基缩醛、9-芴甲氧羰基(Fmoc)、烯丙氧基碳酸酯(Alloc)、叠氮化物和叔丁基二甲基甲硅烷基(TDS)醚的能力。该策略用于合成含KDO的脑膜炎奈瑟菌脂质A(3)。将小鼠巨噬细胞暴露于合成化合物及其亲本LOS、大肠杆菌脂质A(2)以及具有大肠杆菌脂质A不对称酰化模式但脑膜炎球菌脂质A脂质较短的杂合衍生物(4)。检测所得上清液中肿瘤坏死因子α(TNF-α)和干扰素β(IFN-β)的产生。含KDO的脂质A衍生物比单独的脂质A活性高得多,且活性仅略低于其亲本LOS,这表明一个KDO部分足以实现TNF-α和IFN-β诱导的全部活性。脑膜炎奈瑟菌的脂质A比大肠杆菌脂质A诱导TNF-α和IFN-β的能力明显更强,这是由于其许多脂肪酸较短。这些化合物未表现出对MyD88或TRIF依赖性反应的偏向性。